PMV Pharmaceuticals, Inc. (PMVP) Form 8-K Material Events
PMV Pharmaceuticals, Inc. (PMVP) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PMVP
CIK: 1699382
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerAmy Dorfmeister
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-05 | 2026-10-01 | 4 Filing | 0002156044-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-10-05 | 2026-10-01 | 3 Filing | 0002156044-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-10-05 | 2026-10-01 | 8-K | 0001193125-26-413254 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-15 | — | SCHEDULE 13G Filing | 0001699737-26-000021 | View SEC Doc Filr Page |
| 8-K | 2026-09-02 | 2026-08-31 | 8-K | 0001193125-26-378838 | View SEC Doc Filr Page |
| 424B5 | 2026-09-02 | — | 424B5 | 0001193125-26-378780 | View SEC Doc Filr Page |
| 424B3 | 2026-08-31 | — | 424B3 | 0001193125-26-377000 | View SEC Doc Filr Page |
| 424B5 | 2026-08-31 | — | 424B5 | 0001193125-26-376860 | View SEC Doc Filr Page |
| 8-K | 2026-08-31 | 2026-08-31 | 8-K | 0001193125-26-376723 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001193125-26-350448 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | 8-K | 0001193125-26-350445 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-28 | — | SCHEDULE 13G/A Filing | 0001214659-26-009110 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-10 | — | SCHEDULE 13G/A Filing | 0001172661-26-002568 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 Filing | 0001644348-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 Filing | 0001124164-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 Filing | 0001329959-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 Filing | 0001797209-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 Filing | 0001579824-26-000003 | View SEC Doc Filr Page |
| 8-K | 2026-06-05 | 2026-06-04 | 8-K | 0001193125-26-258466 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001012975-26-000440 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001193125-26-218227 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001193125-26-218225 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-04 | — | SCHEDULE 13G/A Filing | 0001214659-26-005496 | View SEC Doc Filr Page |
| ARS | 2026-04-22 | 2025-12-31 | ARS | 0001140361-26-016040 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-22 | — | DEFA14A | 0001140361-26-016039 | View SEC Doc Filr Page |